Blood gases (PCO2, PO2) and blood pH test system; ABL800 FLEX; Model Number 393-801; UDI (01)0570...
FDA Device Recall #Z-2494-2020 — Class II — May 26, 2020
Recall Summary
| Recall Number | Z-2494-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 26, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Radiometer Medical ApS |
| Location | Bronshoj |
| Product Type | Devices |
| Quantity | 3,899 units |
Product Description
Blood gases (PCO2, PO2) and blood pH test system; ABL800 FLEX; Model Number 393-801; UDI (01)05700693938011. Model 393-801 is available as ABL837. The FlexQ module is optional and can be added to all models and configurations.
Reason for Recall
Potential risk of patient mix-up on analyzers due to software issues.
Distribution Pattern
US - AL, AR, AZ, BM, CA, CO, CT, DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV and WY. OUS - Australia, Austria, Canada, Czech Republic, China, Croatia, Denmark, France, Finland, Germany, Hungary, India, Italy, Japan, Netherlands, Norway, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey and United Kingdom
Lot / Code Information
Software versions 6.19 and below.
Other Recalls from Radiometer Medical ApS
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1659-2025 | Class II | Radiometer ABL90 Series - Radiometer ABL90 FLEX... | Mar 21, 2025 |
| Z-2426-2024 | Class II | ABL800 FLEX Model Numbers 393-800 and 393-801 ... | May 31, 2024 |
| Z-1394-2023 | Class II | AQURE REF 933-599 Software Versions 2.5.2 2... | Mar 8, 2023 |
| Z-1321-2022 | Class II | ABL800 Flex Analyzer Model Numbers 393-800 and ... | May 18, 2022 |
| Z-1115-2022 | Class II | Radiometer, REF:956-552, PIC050- Arterial Blood... | Apr 8, 2022 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.